TheCharcotFootinDiabetes
LEEC. ROGERS,DPM
1
ROBERTG. FRYKBERG,DPM, MPH
2
DAVIDG. ARMSTRONG,DPM, PHD
3
ANDREWJ.M. BOULTON,MD
4
MICHAELEDMONDS,MD
5
GEORGESHAVAN,MD
6
AGNESHARTEMANN,MD
6
FRANCESGAME,MD
7
WILLIAMJEFFCOATE,MD
7
ALEXANDRAJIRKOVSKA,MD
8
EDWARDJUDE,MD
4
STEPHANMORBACH,MD
9
WILLIAMB. MORRISON,MD
10
MICHAELPINZUR,MD
11
DARIOPITOCCO,MD
12
LEESANDERS,DPM
13
DANEK. WUKICH,MD
14
LUIGIUCCIOLI,MD
15
The diabetic Charcot foot syndrome is a serious and potentially limb-threatening lower-extremity
complication of diabetes. First described in 1883, this enigmatic condition continues to chal-
lenge even the most experienced practitioners. Now considered an inflammatory syndrome, the
diabetic Charcot foot is characterized by varying degrees of bone and joint disorganization
secondary to underlying neuropathy, trauma, and perturbations of bone metabolism. An in-
ternational task force of experts was convened by the American Diabetes Association and the
American Podiatric Medical Association in January 2011 to summarize available evidence on the
pathophysiology, natural history, presentations, and treatment recommendations for this entity.
Diabetes Care34:2123–2129, 2011
T
he Charcot foot in diabetes poses
many clinical challenges in its di-
agnosis and management. Despite
the time that has passed since thefirst
publication on pedal osteoarthropathy in
1883, we have much to learn about the
pathophysiology, and little evidence ex-
ists on treatments of this disorder. The
international task force was convened in
January 2011 at the Salpêtrière Hospital
in Paris, France, to review the literature
and report on the definition, pathogene-
sis, diagnosis, and treatment of the dia-
betic Charcot foot. Recommendations in
this report are solely the opinions of the
authors and do not represent the official
positions of the American Diabetes Asso-
ciation or the American Podiatric Medical
Association.
DEFINITION—Charcot neuropathic
osteoarthropathy (CN), commonly re-
ferred to as the Char
糖尿病夏科足（国际专家共识）-2011.pdf